Benzinga··PrnewswireKLYG Cuts Losses 85% Despite Revenue Dip, Secures FDA Win for Fusion Implants
$KLYG reported 85% net loss improvement to $138.6K on $3.05M revenue, secured FDA clearance for Fusion™ cranial implants, rejected acquisition offer.
KLYGFDA clearancenet loss improvement